Man Group PLC Axonics, Inc. Transaction History

Man Group PLC

$37.6 Billion
Q2 2024

A detailed history of Man Group PLC transactions in Axonics, Inc. stock. As of the latest transaction made, Man Group PLC holds 956,801 shares of AXNX stock, worth $67.4 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

956,801

Previous 790,427 21.05%

Holding current value

$67.4 Million

Previous $54.5 Million 18.0%

% of portfolio

0.17%

Previous 0.14%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$66.47 - $69.65 $11.1 Million - $11.6 Million	166,374 Added 21.05%	956,801 $64.3 Million
Q1 2024 May 15, 2024	BUY	$56.67 - $69.36 $44.8 Million - $54.8 Million	790,427 New	790,427 $54.5 Million
Q2 2023 Aug 14, 2023	SELL	$47.99 - $60.21 $2.68 Million - $3.36 Million	-55,812 Reduced 15.22%	310,803 $15.7 Million
Q1 2023 May 15, 2023	BUY	$52.6 - $67.34 $5.43 Million - $6.95 Million	103,137 Added 39.14%	366,615 $20 Million
Q4 2022 Feb 14, 2023	BUY	$59.56 - $76.6 $3.24 Million - $4.16 Million	54,346 Added 25.99%	263,478 $16.5 Million
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $9.66 Million - $13 Million	166,723 Added 393.13%	209,132 $14.7 Million
Q2 2022 Aug 15, 2022	BUY	$39.5 - $64.42 $1.52 Million - $2.48 Million	38,549 Added 998.68%	42,409 $2.4 Million
Q1 2022 May 16, 2022	BUY	$43.74 - $62.76 $168,836 - $242,253	3,860 New	3,860 $242,000
Q1 2021 May 17, 2021	SELL	$49.14 - $59.89 $199,655 - $243,333	-4,063 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$42.19 - $51.5 $791,273 - $965,882	-18,755 Reduced 82.19%	4,063 $203,000
Q3 2020 Nov 16, 2020	SELL	$35.33 - $51.04 $335,175 - $484,216	-9,487 Reduced 29.37%	22,818 $1.17 Million
Q2 2020 Aug 14, 2020	BUY	$22.91 - $39.83 $740,107 - $1.29 Million	32,305 New	32,305 $1.13 Million

Others Institutions Holding AXNX

# of Institutions

230

Shares Held

43M

Call Options Held

50.2K

Put Options Held

135K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.46B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account